Progranulin (PGRN) is a growth factor that has been implicated in wound healing, inflammation, infection, tumorigenesis, and is most known for its neuroprotective and proliferative properties in neurodegenerative disease. This pleiotropic growth factor has been found to be a key player and regulator of a diverse spectrum of multisystemic functions. Its critical anti-inflammatory role in rheumatoid arthritis and other inflammatory disease models has allowed for the propulsion of research to establish its significance in musculoskeletal diseases, including inflammatory conditions involving bone and cartilage pathology. In this review, we aim to elaborate on the emerging role of PGRN in the musculoskeletal system, reviewing its particular mechanisms described in various musculoskeletal diseases, with special focus on osteoarthritis and inflammatory joint disease pathomechanisms and potential therapeutic applications of PGRN and its derivatives in these and other musculoskeletal diseases.
CITATION STYLE
Konopka, J., Richbourgh, B., & Liu, C. (2014, January 1). The role of PGRN in musculoskeletal development and disease. Frontiers in Bioscience - Landmark. Bioscience Research Institute. https://doi.org/10.2741/4234
Mendeley helps you to discover research relevant for your work.